Androgen activity in the normal male embryonic hindbrain drives lethal PFA ependymoma
Androgen activity in the normal male embryonic hindbrain drives lethal PFA ependymoma
Dr. Jiao Zhang, Ph.D. – Baylor College of Medicine, Houston TX
HBEGF as a novel therapeutic target for Diffuse Midline Glioma
HBEGF as a novel therapeutic target for Diffuse Midline Glioma
Dr. Oren Becher, M.D. – Icahn School of Medicine at Mount Sinai, New York, NY
Therapeutic targeting of CDK12/13 and PARP in H3G34RN mutant pediatric glioma
Therapeutic targeting of CDK12/13 and PARP in H3G34RN mutant pediatric glioma
Dr. Jamie Anastas, Ph.D. – Baylor College of Medicine, Houston, TX
Preclinical evaluation of omacetaxine as a novel therapeutic for ATRT
Preclinical evaluation of omacetaxine as a novel therapeutic for ATRT
Dr. John Prensner, M.D., Ph.D. – University of Michigan Medical Center (Michigan Medicine), Ann Arbor, MI
Developing Human Cerebellar Organoid Models of Group 4 Medulloblastoma to Identify the Cell of Origin and Mechanisms that Support Oncogenesis
Developing Human Cerebellar Organoid Models of Group 4 Medulloblastoma to Identify the Cell of Origin and Mechanisms that Support Oncogenesis
Dr. Yanxin Pei, M.D. – Children's Research Institute (CNMC), Washington, D.C.
Brain Network Organization and Long-Term Cognitive Outcome in Pediatric Brain Tumor Patients
Brain Network Organization and Long-Term Cognitive Outcome in Pediatric Brain Tumor Patients
Dr. Stephanie Perkins – Washington University in St. Louis, St Louis, MO
Dual-label optical genome mapping for the identification of novel co-occurring genetic and epigenetic alterations in diffuse midline gliomas
Dual-label optical genome mapping for the identification of novel co-occurring genetic and epigenetic alterations in diffuse midline gliomas
Dr. Miriam Bornhorst – Children's National Health System Department of Neurology, Washington D.C.
Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma
Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma
Dr. Oren Becher – Icahn School of Medicine at Mount Sinai, New York, NY
Epigenetic targeting of radiation resistant medulloblastoma
Epigenetic targeting of radiation resistant medulloblastoma
Johns Hopkins University, Baltimore, MD
Enhancement of Oncolytic Virotherapy with Directed Drug Delivery for Pediatric Brain Tumors
Enhancement of Oncolytic Virotherapy with Directed Drug Delivery for Pediatric Brain Tumors
MD Anderson Cancer Center, Houston, TX
PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy
PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy
University of Colorado Denver, AMC and DC, Aurora, CO
Exploiting NAD Metabolism Defects in Pediatric Brain Tumors
Exploiting NAD Metabolism Defects in Pediatric Brain Tumors
Yale University, New Haven, CT
Stimulating Macrophages to Eat Pediatric Brain Cancer: Combining Anti-CD47 and Irradiation to Enhance the Treatment of Group 3 Medulloblastoma
Stimulating Macrophages to Eat Pediatric Brain Cancer: Combining Anti-CD47 and Irradiation to Enhance the Treatment of Group 3 Medulloblastoma
University of Utah, Salt Lake City, UT
Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma
Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma
Beckman Research Institute of the City of Hope, Duarte, CA
Boosting Immunovirotherapy with Tumor Vaccination to Treat Pediatric Malignant Brain Tumors
Boosting Immunovirotherapy with Tumor Vaccination to Treat Pediatric Malignant Brain Tumors
University of Alabama at Birmingham, Birmingham, AL
A Novel Approach to Target ACVR1 as a Treatment to Pediatric Cancer
A Novel Approach to Target ACVR1 as a Treatment to Pediatric Cancer
Georgia Tech Research Corporation, Atlanta, GA
Overcoming Innate Immune Evasion in Pediatric High Grade Glioma
Overcoming Innate Immune Evasion in Pediatric High Grade Glioma
University of Colorado Denver, AMC and DC, Aurora, CO
Targeting MEK and CDK4/6 in DIPG
Targeting MEK and CDK4/6 in DIPG
Lurie Children’s Hospital, Chicago, IL
Improving Brain Tumor Targeted Antigen Receptor T Cell Function
Improving Brain Tumor Targeted Antigen Receptor T Cell Function
City of Hope, Duarte, CA
In-Vivo Organogenesis Approach to Elucidate Drivers of Medulloblastoma Development and Identify Therapeutic Targets
In-Vivo Organogenesis Approach to Elucidate Drivers of Medulloblastoma Development and Identify Therapeutic Targets
University of California, San Francisco, CA